KFA Browser > Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi

Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi

  1. General Information
  2. ATC Groups
  3. Product Hierarchy

General Information

KFA Code (PV) 92003142
Type Vaksin
Unit of Measure (UCUM) milliliter
Dosage Form Suspensi Injeksi
Drug Classification Obat Keras
Route Administration Intramuskular Injeksi (di dalam otot)

CVX Info

CVX Code 212
Vaccine Group COVID-19

Anatomical Therapeutic Chemical Groups

Chemical Substance (INN) J07BX03 - Covid-19 vaccines
Anatomical Main Group J - ANTIINFECTIVES FOR SYSTEMIC USE
Therapectic Subgroup J07 - VACCINES
Pharmacological Subgroup J07B - VIRAL VACCINES
Chemical Subgroup J07BX - Other viral vaccines
Alternative Name (USAN) SARS-COV-2 (COVID-19) vaccine, vector - Ad26
Kamus Farmalkes (KFA – IHS) 92003142 - Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi